<?xml version='1.0' encoding='utf-8'?>
<document id="21031626"><sentence text="Reversible inhibition of three important human liver cytochrome p450 enzymes by tiliroside."><entity charOffset="80-90" id="DDI-PubMed.21031626.s1.e0" text="tiliroside" /></sentence><sentence text="Tiliroside, an active flavonoid extensively found in many medicinal plants including Helichrysum italicum, Geranium mexicanum and Helianthemum glomeratum, has been demonstrated to exert multiple biological effects including antiinflammatory, antimicrobial, antioxidant and antitumor activities"><entity charOffset="0-10" id="DDI-PubMed.21031626.s2.e0" text="Tiliroside" /><entity charOffset="22-31" id="DDI-PubMed.21031626.s2.e1" text="flavonoid" /><pair ddi="false" e1="DDI-PubMed.21031626.s2.e0" e2="DDI-PubMed.21031626.s2.e0" /><pair ddi="false" e1="DDI-PubMed.21031626.s2.e0" e2="DDI-PubMed.21031626.s2.e1" /></sentence><sentence text=" Cytochrome P450 (CYP) enzymes play an important role in the Phase I oxidation metabolism of a wide range of xenobiotics and inhibition of CYP isoforms might influence the elimination of drugs and induce serious adverse drug response" /><sentence text=" The inhibition of seven CYP isoforms (CYP3A4, CYP1A2, CYP2A6, CYP2D6, CYP2C9, CYP2C8 and CYP2E1) by tiliroside was investigated using in vitro human liver microsomal incubation assays"><entity charOffset="101-111" id="DDI-PubMed.21031626.s4.e0" text="tiliroside" /></sentence><sentence text=" The results showed that tiliroside strongly inhibited the activity of CYP3A4 (IC(50) = 9"><entity charOffset="25-35" id="DDI-PubMed.21031626.s5.e0" text="tiliroside" /></sentence><sentence text="0 ± 1" /><sentence text="7 μm), CYP2C8 (IC(50) = 12" /><sentence text="1 ± 0" /><sentence text="9 μm) and CYP2C9 (IC(50) = 10" /><sentence text="2 ± 0" /><sentence text="9 μm) with other CYP isoforms negligibly influenced" /><sentence text=" Further kinetic analysis showed that inhibition of these three CYP isoforms by tiliroside is best fit to a competitive way"><entity charOffset="80-90" id="DDI-PubMed.21031626.s12.e0" text="tiliroside" /></sentence><sentence text=" The K(i) value was calculated to be 5" /><sentence text="5 μm, 3" /><sentence text="3 μm, 9" /><sentence text="4 μm for CYP3A4, CYP2C9 and CYP2C8, respectively" /><sentence text=" The relatively low K(i) values suggested that tiliroside might induce drug-drug interactions with many clinically used drugs which are mainly metabolized by these three CYP isoforms"><entity charOffset="47-57" id="DDI-PubMed.21031626.s17.e0" text="tiliroside" /></sentence><sentence text=" Therefore, attention should be given to the probable drug-drug interaction between tiliroside-containing herbs and substrates of CYP3A4, CYP2C9 and CYP2C8" /><sentence text="" /></document>